Diabetes

The celebrated rule change did not translate into an easy transition with Medicare Administrative Contractors or suppliers of durable medical equipment.

The study of electronic medical records showed that patients on the SGLT2 inhibitor stayed on the medication longer, although both groups took the same amount of time to get their A1C below 8%.

A new study finds that sugar-sweetened beverages have become more affordable relative to income in 79 of 82 countries analyzed. The authors suggested that soda taxes may be an important tool in curtailing the rise of obesity and diabetes.

The study may help explain a phenomenon noticed by researchers and primary care physicians alike: adults in their 40s may eat less and exercise more, but not see the results in weight loss.

The findings will likely reopen discussion of what to do when patients report muscle-related symptoms from statins.

The study's authors say the findings show the need to find the right balance between guarding against skin cancer and getting enough vitamin D.

People with diabetes are particularly in need of regular eye exams to get for signs of diabetic retinopathy, which can lead to blindness.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

A new study has found that patients with early stage type 2 diabetes (T2D) are more likely to have structural abnormalities in the brain and cognitive difficulties, particularly if they are overweight or obese.

While the report documents the shortage of DSME programs in rural areas, it does not address the reimbursement challenges that confront the use of telehealth to reach underserved groups.

While there are many hurdles to overcome before the technology could be ready for commercial use, the experiment shows what could be possible for people living with diabetes.

The study from King's College of London is the latest to sound the alarm about rising incidence of type 2 diabetes among youth.

Racial or ethnic minorities are less likely to have insurance that covers treatments for obesity, even though they are at higher risk of the disease, explained Fatima Cody Stanford, MD, MPH, MPA, FAAP, FTOS, of Harvard Medical School and Massachusetts General Hospital.

Research over the past decade has found connections between poor sleep and obesity, but this is the first study to examine the connections among bedtimes in young children, emotional self-regulation, and obesity later in life.

The most common modifiable behavioral risk factors identified in the study are all treatable, suggesting that prevention could go a long way toward reducing their impact.

One of the best ways to increase compliance when treating diabetes is to ensure patients fully understand the importance of treatment, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America. However, this can be difficult for physicians with a limited amount of time for patient visits.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

A new study finds that the prevalence of diabetes is significantly higher among non-obese Filipino Americans aged 50 and older than in their white counterparts, even after controlling for lifestyle factors.

This week, the top managed care stories included a new rule from CMS to end abuse on the Affordable Care Act insurance exchanges; a study that indicates type 2 diabetes may possibly be reversed; and CareMore unveils a new care model that takes place in the dentist's chair.

Standard biomarker tests miss many patients who develop kidney failure. Also, many patients who are not at high risk end up in clinical trials, adding expense when they will not help researchers prove anything.

The study from Finland evaluated the diets of men taking part in a larger study of heart disease risk.

This study describes a widespread variation in medication adherence, pharmacy cost sharing, and medical spending. Increased cost sharing may decrease adherence and increase total diabetes spending.